
Insiders Updates
Insider Sale Alert: Allogene Therapeutics Inc [ALLO] – Is it Time to sell?
Allogene Therapeutics Inc’s recently made public that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun
Allogene Therapeutics Inc’s recently made public that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun
Allogene Therapeutics Inc’s recently made public that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun
Allogene Therapeutics Inc’s filing revealed that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun 10
Allogene Therapeutics Inc’s filing revealed that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun 10
Allogene Therapeutics, Inc. (ALLO), a clinical-stage immuno-oncology company, has dipped 32.73% and hence, ALLO stock was trading at $16.40 when